The United States has revealed price reductions for the second round of | The U.S. has revealed price reductions for the ...

The agency is able to negotiate some drug prices for Medicare recipients because of a bill signed by former President Joe ...

The discounts should be compared against the drugs’ “ultimate net price” rather than their indicated list price to gauge the ...

The Trump administration late Tuesday announced new lower Medicare prices for 15 drugs that were part of the latest round of the program’s price negotiations, touting a total of $12 billion ...

Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include ...

The Trump administration tapped a Biden-era rule to negotiate lower prices on 15 widely used medications for seniors.

Novo Nordisk shares rose 5% on Wednesday after analysts said that U.S. price cuts for the Danish drugmaker's semaglutide came in broadly as expected.

Medicare will save approximately 44%, on 15 high-cost medications as a result of the second round of the program’s drug price ...

Medicare will cap prices on 15 more drugs, including Ozempic, with cuts starting in 2027 under Trump administration policy.

Price are falling sharply for Medicare beneficiaries prescribed Novo Nordisk’s GLP-1 drugs like Ozempic in 2027.

Negotiations are expected to continue in future cycles as part of President Donald Trump's "aggressive push for lower prices." ...